Dragon fruit

Dragon Fruit (Hylocereus spp. / Selenicereus spp.): A Comprehensive Reference

1. Identity: Botanical Classification, Common Names, and Natural Source

Dragon fruit, otherwise called pitaya or pitahaya, is an edible fruit of the Hylocereus genus. It belongs to the cactus family Cactaceae and is characterized by its rich vitamin C content and water-soluble fiber in its pulp. The taxonomy of dragon fruit has been subject to ongoing revision; many species formerly classified under Hylocereus are now reclassified into the genus Selenicereus.

The three commercially dominant species are: Selenicereus undatus (also known as Hylocereus undatus), commonly called pitaya blanca, which has pink-skinned fruit with white flesh and is the most commonly seen "dragon fruit"; Selenicereus costaricensis (also known as Hylocereus costaricensis), called pitaya roja, which has red-skinned fruit with red flesh; and Selenicereus megalanthus (also known as Hylocereus megalanthus), called pitaya amarilla or yellow pitaya, which has yellow-skinned fruit with white flesh.

Hylocereus species are herbaceous perennial climbing cacti mainly distributed in subtropical and tropical regions, and are highly tolerant to drought. The plant is native to Southern Mexico, Guatemala, and Costa Rica. These fruits are commonly known in English as "strawberry pear" or "dragon fruit," a name used since 1963, apparently resulting from the leather-like skin and prominent scaly spikes on the fruit exterior.

Additional common names in use across different regions include night-blooming cereus and pitaya roja. The names pitahaya and pitaya derive from Mexico, and pitaya roja in Central America and northern South America, possibly relating to pitahaya for names of tall cacti species with flowering fruit. The term "pitahaya" comes from the Antilles and means "scaly fruit."

Forms and Preparations

Dragon fruit is consumed and prepared in a variety of forms:

• Fresh whole fruit: The fruit normally weighs from 150 to 600 grams; some may reach 1 kg. The flesh is consumed raw, scooped directly from the halved fruit.
• Freeze-dried powder: Used in clinical research and as a dietary supplement. The King's College London vascular study employed 24 g whole dragon fruit powder (containing 33 mg betalains) daily for 14 days.
• Juice and concentrated juice: Used in several clinical trials evaluating glycemic and lipid effects.
• Dried powder capsules/sachets: Used in prebiotic oligosaccharide research at defined doses.
• Flowers: The flowers can be eaten or steeped as tea.
• Food colorant: Dragon fruit is used to flavor and color juices and alcoholic beverages.

2. Traditional and Historical Use

Pitaya is native to the region of southern Mexico and along the Pacific coasts of Guatemala, Costa Rica, and El Salvador. The Hylocereus undatus, commonly known as dragon fruit or pitahaya, was first propagated and cultivated by birds and humans for its edible fruits in many tropical regions of the Americas and the Caribbean during pre-Columbian times.

The historical record regarding early dietary use in Mesoamerica is incomplete. The origin of pitahaya is surrounded by uncertainty; archaeological remains or historical sources that can definitively confirm whether this fruit was consumed in pre-Hispanic Mexico are lacking. However, pre-Hispanic cultures were known to consume fruits from cacti, so consumption of dragon fruit by these populations is plausible.

The introduction of the fruit to Southeast Asia is attributed to French colonists, who brought the plant to Indochina around the 1860s, marking its establishment in a new hemisphere far from its natural environment. Today, the commercial landscape for dragon fruit is dominated by these introduced regions, which are now the world's largest producers; Vietnam stands out as the leading global supplier, accounting for over half of the world's commercial volume.

In some Asian cultures, the fruit, particularly red varieties, is sometimes associated with prosperity and good fortune, often given as gifts during festive occasions. It has also been used in traditional medicine practices in various cultures, although scientific validation for many such uses is ongoing.

Dragon fruit has traditionally been used as a coloring agent, and some newly explored therapeutic applications include its use as an antioxidant, antimicrobial, antidiabetic, anticancer, and nutraceutical. In Vietnam, where the plant has been cultivated for over a century, the flowers have historically been brewed into teas.

3. Key Constituents and Active Compounds

3.1 Macronutrient Composition

The pH, total soluble solids, total sugar, moisture, ash, protein, and dietary fibre content vary between 4.8–5.4, 8–12%, 5.13–7.06%, 82–85%, 0.7–0.85%, 0.90–1.1%, and 0.8–1.0%, respectively, across the main species. The fruit is low in calories and fat, making it a low-energy-density food.

3.2 Vitamins and Minerals

Per 100 g of fruit, mineral content includes approximately 120–200 mg potassium, 30–45 mg magnesium, 20–45 mg calcium, 20–35 mg phosphorus, 0.70–1.5 mg iron, and 0.20–0.40 mg zinc. Vitamin C was found as the predominant vitamin at up to 6 mg/100 g, followed by vitamin E (150 µg), pantothenic acid (50 µg), and vitamin K1 (25 µg).

3.3 Betalains: Betacyanins and Betaxanthins

Betalains are the principal bioactive pigments in red-fleshed dragon fruit. The color of H. polyrhizus is contributed by betacyanin, a compound from a set of water-soluble nitrogen-containing pigments known as betalains. Betalains play a vital role as the major antioxidant contributor in H. polyrhizus, whereas non-betalainic phenolic compounds play a minor role. Betalains comprise betacyanins (red-purple) and betaxanthins (yellow); however, betaxanthins are absent in H. polyrhizus, and only betacyanins can be found.

Betalains are the principal phytochemicals in dragon fruits and consist of betacyanins and betaxanthins. The biosynthesis pathway of betaxanthins and betanin in plants involves three enzymes: a tyrosine hydroxylase (TYH), a DOPA-4,5-extradiol dioxygenase (DOD), and a UDP-glycosyltransferase (UGT) that is either active on cDOPA or on betanidin.

The stability of betacyanin is affected by heat, oxygen, light, pH, and moisture, which are the main causes for discoloration of this pigment. The primary degradation products of betacyanin are the colorless cyclo-dopa 5-O-β-glucoside and bright yellow betalamic acid.

3.4 Phenolic Compounds and Flavonoids

Total phenolics and flavonoids content vary between 25–55 mg GAE and 15–35 mg CE per 100 g, respectively. H. polyrhizus has a significantly higher quantum of phenolics and antioxidant potential than H. undatus.

Comparatively high phenol (71.3–161.3 mg) and flavonoid (26.6–508.2 mg) content have been observed in peels compared to pulp (32.5–130.0 and 45.0–258.2, respectively), indicating higher antioxidant potential in the peel. The flowers and fruits of the plant contain the flavonoids kaempferol, quercetin, isorhamnetin, and derived compounds.

Studies have shown that pitaya contains bioactive compounds that may include vitamins, potassium, betacyanin, p-coumaric acid, vanillic acid, and gallic acid.

3.5 Carotenoids

The highest total carotenoids (µg/100 g), β-carotene (µg/100 g), and xanthophyll (µg/g) content in pulp have been recorded at 33.8, 55.9, and 32.7, respectively, depending on the species studied. The fruit is also known to be a rich source of lycopene.

3.6 Oligosaccharides and Dietary Fiber

The prebiotic principle in dragon fruits is oligosaccharides, which stimulate the growth of beneficial gut microbiota, including Bifidobacterium and Faecalibacterium; improve the immune system by increasing immunoglobulin A and G; and may help in preventing intestinal diseases like colon cancer.

3.7 Seed Oil Composition

Dragon fruit is also a rich source of oligosaccharides, fats with a high proportion of essential fatty acids, and pigments like β-carotene and lycopene. The black seeds distributed throughout the flesh contribute polyunsaturated fatty acids, though this area has been less extensively characterized in peer-reviewed clinical literature.

3.8 Established Mechanisms of Action

Based on in vitro and animal research, several mechanisms have been proposed:

• Free radical scavenging: DPPH-based scavenging activity (%) has revealed higher scavenging activity of peels (55.6–81.2%) than pulp (36.0–75.3%) extracts across different species.
• Anti-inflammatory activity via betalains: Anti-inflammatory activity of encapsulated betalains from red dragon fruit peel was demonstrated to be five- to six-fold higher than that of non-encapsulated betalains in duck embryo chorioallantoic membrane vascular irritation assays.
• Glutathione S-transferase (GST) induction: GST-inducing activity of betalains from red dragon fruit peel was likewise improved four- to five-fold by carbohydrate encapsulation, demonstrating that the antioxidant, anti-inflammatory, antiangiogenic, and GST-inducing activities of betalains were enhanced through carbohydrate encapsulation.
• Insulin sensitivity improvement: White pitaya juice and purified peel betacyanins improved insulin resistance through decreasing fibroblast growth factor-21 (FGF-21) expression and increasing levels of FGF-21-related genes (Klb, FGFR2, Egr1, and cFos) in the liver.
• Pancreatic protection: Dragon fruit is a rich source of natural antioxidants including betacyanin, flavonoid, phenolic acid, ascorbic acid, and fiber. With high antioxidant and free radical-scavenging activity, it has a preventive effect on the histopathological picture of pancreatic β cells in alloxan-induced diabetic rats by reducing reactive oxidative species.
• Prebiotic modulation: Dragon fruit oligosaccharides promote the growth and activity of beneficial bacteria (probiotics) while regulating the growth of harmful bacteria. The indirect pathway to the gut immune response proceeds through microbiota-dependent molecular mechanisms and their fermentation products such as short-chain fatty acids (SCFAs), which are important as an energy source for epithelial cells and serve as potential mediators involved in gut microbiota and intestinal immune functions.

4. Scientific Evidence by Area of Use

4.1 Glycemic Control (Diabetes and Prediabetes)

This is the most extensively studied area for dragon fruit in human clinical trials.

Systematic review and meta-analysis (PLOS ONE, 2017): Among 401 studies identified from a comprehensive literature search, 4 RCTs involving 36 prediabetes subjects and 109 type 2 diabetes patients were included in the analysis. In prediabetes, fasting plasma glucose (FPG) reduction was significant with a mean difference of −15.1 mg/dL (95% CI: −23.8 to −6.5 mg/dL, P = 0.0006). Meta-analysis in type 2 diabetes showed no statistically significant effect of dragon fruit on FPG (MD −26.5 mg/dL, 95% CI: −72.6 mg/dL to 19.6 mg/dL) and in 2-hour post-prandial glucose (MD −30.5 mg/dL, 95% CI: −80.9 mg/dL to 19.9 mg/dL).

The authors concluded that the available evidence in prediabetes is interesting, shedding some light on diabetes prevention. The effect in type 2 diabetes was not significant; however, a trend towards greater blood glucose reduction with higher dose was observed.

Methodological limitations: Overall, the included studies had a moderate risk of bias. Most of them lacked clarity of methodological information for random sequence generation, allocation concealment, double-blinding, and withdrawal or dropout reporting, which are essential for assessment of risk of bias.

Evidence strength: Evidence for glycemic benefit in prediabetes is preliminary but directionally consistent. Evidence in established type 2 diabetes is not statistically significant based on available RCTs. The evidence base is limited by small sample sizes, methodological weaknesses, and the use of different dragon fruit preparations and doses across trials. Further research, including long-term clinical trials involving larger sample sizes, is warranted to corroborate these findings and elucidate underlying mechanisms.

4.2 Cardiovascular and Vascular Function

Randomized controlled crossover trial (American Journal of Clinical Nutrition, 2022): A randomized, double-blind, placebo-controlled, crossover trial was conducted in 19 young, healthy, nonsmoking men and women assigned to consume 24 g whole dragon fruit powder (33 mg betalains) or a nutrient-matched placebo daily for 14 days to investigate the effects of acute and short-term consumption of dragon fruit on vascular function.

Acute and short-term consumption of dragon fruit in dietary achievable amounts improved endothelial function and arterial stiffness in healthy individuals. The authors concluded that regular dragon fruit consumption may have a meaningful impact on cardiovascular disease risk, likely due to the high betalain content.

A prior systematic review examining available evidence on the effects of betalain-rich dragon fruit and cactus pear on vascular function failed to find any human RCT linking dragon fruit consumption to vascular markers, representing an important gap in the literature. The 2022 King's College trial was the first RCT to address this gap.

Evidence strength: A single small RCT (n=19 healthy young adults) showed improvements in endothelial function and arterial stiffness. While the trial design was rigorous (double-blind, placebo-controlled, crossover), the small population size and restriction to healthy young individuals limits generalizability. Evidence is preliminary and requires replication in larger, more diverse populations and in individuals with existing cardiovascular risk.

4.3 Lipid Profile

Betalains are natural red color pigments abundant in red-fleshed dragon fruit (Hylocereus polyrhizus). Recent research has shown that dragon fruit consumption may help improve blood glucose and lipid profile. Several of the trials included in the 2017 meta-analysis also assessed lipid parameters, with primary outcomes in the five human clinical trials including improved glycemia, lipid profile, and antioxidant status, as well as flow-mediated dilation and arterial stiffness.

Results from pre-diabetic subjects consuming red pitaya powder (RPP) drinks showed positive effects in increasing HDL-C and total antioxidant status (TAS) levels while simultaneously lowering glucose, total cholesterol, triglycerides, and LDL-C levels.

Evidence strength: Evidence for lipid-modifying effects is largely derived from animal models and small human studies. Results are directionally positive but do not yet meet the threshold for confident clinical recommendation.

4.4 Gut Microbiota and Prebiotic Effects

Randomized double-blind placebo-controlled study (Food Research International, 2023): The first clinical study confirmed the safety and efficacy of dragon fruit oligosaccharides (DFO) as an emerging prebiotic. DFO improved the immune system (serum IgA) at even a low dose (4 g/day). DFO at 8 g/day outstandingly promoted the growth of Bifidobacterium spp. and decreased harmful bacteria, especially Escherichia coli.

The potential dose of DFO for healthy adults was established as 4 g/day for improving IgA level and 8 g/day for promoting beneficial gut microbiota.

Animal study supporting data: In an earlier rat study, DFO significantly increased fecal bifidobacteria and lactobacilli while decreasing bacteroides and clostridia. DFO also showed immune-response boosting properties by significantly increasing plasma immunoglobulin A and G concentrations, and blood chemistry analysis and histology of rat colon confirmed DFO's suitability for consumption.

Evidence strength: One RCT in healthy adults demonstrates prebiotic efficacy of dragon fruit oligosaccharides with clear dose findings. Evidence in this area is among the stronger human clinical evidence available for dragon fruit, though further trials in clinical populations are needed.

4.5 Antioxidant Status

One parallel-design trial investigated the effects of a frozen red dragon fruit beverage on blood pressure, glycemic response, insulinemic response, lipid profile, total antioxidant status (TAS), and C-reactive protein (CRP) levels in healthy subjects and individuals at risk of type 2 diabetes. In vitro antioxidant activity has been consistently demonstrated across multiple laboratory studies.

Besides the importance of dragon fruit as a source of bioactive compounds, the bioavailability of these compounds is noted to be low, which may partially explain the discrepancy between in vitro antioxidant potency and observed clinical effects.

Evidence strength: Strong in vitro and preclinical antioxidant activity data. Human evidence for improved circulating antioxidant markers is limited and indirect.

4.6 Anti-inflammatory Effects

Studies have shown that pitaya can exert several benefits in conditions such as diabetes, dyslipidemia, metabolic syndrome, cardiovascular diseases, and cancer due to the presence of bioactive compounds. Anti-inflammatory evidence at the human clinical level remains indirect; most mechanistic data come from cell-based and animal models.

In vitro studies have shown anti-glycation, anti-diabetes, anti-viral, anti-plasmodium, hepatoprotective, immunomodulatory, and osteogenic effects. These findings are not yet substantiated by dedicated human trials for most of these endpoints.

Evidence strength: Preclinical and in vitro only for most anti-inflammatory endpoints. No dedicated human RCTs specifically evaluating inflammatory biomarkers as primary outcomes have been identified in the literature reviewed.

4.7 Overall Human Evidence Summary

Based on a systematic search across PubMed, EMBASE, Google Scholar, and Cochrane databases, only five clinical trials were identified meeting inclusion criteria for human RCT study of the effects of the genus Hylocereus on human health. All five were performed with H. polyrhizus; three were performed in Malaysia, one in Indonesia, and one in the United Kingdom. This is a notably small body of human evidence for a fruit so widely discussed in the nutritional literature.

5. Body Systems and Health Areas of Association

• Metabolic / Endocrine system: Glycemic regulation in prediabetes; possible role in insulin sensitivity; lipid profile modulation.
• Cardiovascular system: Endothelial function, arterial stiffness, blood pressure; betalain-mediated effects.
• Gastrointestinal system: Prebiotic oligosaccharide activity; dietary fiber contribution; gut microbiota modulation.
• Immune system: Immunoglobulin A and G enhancement in association with prebiotic oligosaccharides.
• Oxidative stress: Free radical scavenging via betalains, vitamin C, polyphenols, and carotenoids; GST induction.
• Skin: Vitamin C contributes to collagen synthesis; the bioactive compounds have antioxidant properties and, in addition to preventing cellular aging, have an anti-inflammatory effect and stimulate collagen synthesis.

6. Dosage Forms and Dosages Reported in Studies

The following dosages are reported directly from cited studies and should not be interpreted as therapeutic recommendations:

• Freeze-dried whole fruit powder (vascular function RCT, King's College London, 2022): 24 g whole dragon fruit powder (containing 33 mg betalains), daily for 14 days.
• Dragon fruit oligosaccharide (DFO) for prebiotic/immune effects (Pansai et al., 2023 RCT): 4 g/day DFO for improving IgA level and 8 g/day DFO for promoting beneficial gut microbiota in healthy adults.
• Animal safety threshold for DFO: DFO is suitable for consumption at dosages of no more than 4 g/kg body weight, and is capable of modulating the gut microbiota and boosting the gut immune response in animal studies.
• Glycemic RCTs: The 2017 meta-analysis noted a trend towards greater blood glucose reduction with higher dose, though specific dosages across the four included RCTs were variable and reported in each individual trial rather than a unified protocol.

No standardized or universally established clinical dose has been defined for dragon fruit or its extracts as a dietary supplement. The dosages above reflect what was used in individual research studies.

7. Safety Considerations and Interactions

7.1 General Safety Profile

Dragon fruit is broadly recognized as a food substance with an established history of safe consumption across many populations. The first formal evaluation of suitability for consumption of dragon fruit oligosaccharide confirmed that DFO is safe for consumption and is a potentially novel source of prebiotic ingredients.

7.2 Benign Pigment Effects

The betalains, pigments that give red dragon fruit its vibrant color, can cause a harmless reddish discoloration of urine and stool. This effect is temporary and subsides once the fruit is eliminated from the body. This phenomenon, known as pseudohematuria, is a commonly documented and clinically insignificant observation that patients and clinicians should be aware of to avoid unnecessary investigation.

7.3 Allergic Reactions

Allergic reactions to dragon fruits are rare but can occur. Some individuals may exhibit allergic reactions to dragon fruit; symptoms could range from mild (itching, rash, or hives) to severe (difficulty breathing, swelling of the face, lips, or throat). Individuals with latex allergies may also experience allergic reactions to dragon fruit due to cross-reactivity. People with pre-existing allergies to kiwi, bananas, or latex may be more prone to pitaya-related allergic reactions.

7.4 Gastrointestinal Effects

Gastrointestinal issues may arise with consumption of large amounts of dragon fruit. Abdominal discomfort and bloating may occur in cases where excessive amounts of fibre are consumed.

7.5 Drug Interactions

The scientific evidence regarding interactions between dragon fruit and medications is currently lacking. Several theoretical interactions have been noted in the literature:

• Antidiabetic medications: Dragon fruit may lower blood sugar levels, potentially enhancing the effects of diabetes medications. Given the evidence for FPG reduction in prediabetes, this interaction deserves monitoring in individuals using glucose-lowering pharmacotherapy.
• Vitamin C–mediated interactions: Dragon fruit is generally safe to consume and does not typically interact with most medications; however, due to its high vitamin C content, it could potentially affect the absorption of certain drugs like beta-blockers and statins.

7.6 Bioavailability Limitations

Besides the importance of dragon fruit as a source of bioactive compounds, the bioavailability of these compounds is low. The development of delivery systems such as gold nanoparticles with these compounds can be an alternative approach to reach target tissues. This has practical implications for the translation of in vitro findings to clinical outcomes, and is an active area of food science and pharmaceutical research.

References

• Karunakaran G et al. (2021). Biochemical and nutritional characterization of dragon fruit (Hylocereus species). PubMed/NCBI.
• Scientific Reports (2021). Distinguishing three Dragon fruit (Hylocereus spp.) species using morphological, biochemical and molecular traits. PMC/NCBI.
• Wikipedia. Pitaya.
• PMC (2025). Yellow Pitahaya (Selenicereus megalanthus Haw.): The Less Known of the Pitahayas.
• PMC (2015). Effects of heat, pH, antioxidant, agitation and light on betacyanin stability using red-fleshed dragon fruit (Hylocereus polyrhizus) juice and concentrate as models.
• PubMed (2016). Health-promoting bioactivities of betalains from red dragon fruit (Hylocereus polyrhizus) peels as affected by carbohydrate encapsulation.
• PMC (2024). Betalains: A Narrative Review on Pharmacological Mechanisms Supporting the Nutraceutical Potential Towards Health Benefits.
• PMC (2023). Anti-Inflammatory, Antioxidant, and Other Health Effects of Dragon Fruit and Potential Delivery Systems for Its Bioactive Compounds. MDPI Pharmaceutics.
• Poolsup N, Suksomboon N, Paw N. (2017). Effect of dragon fruit on glycemic control in prediabetes and type 2 diabetes: A systematic review and meta-analysis. PLOS ONE.
• Cheok A, Xu Y, Zhang Z, Caton PW, Rodriguez-Mateos A. (2022). Betalain-rich dragon fruit (pitaya) consumption improves vascular function in men and women: a double-blind, randomized controlled crossover trial. American Journal of Clinical Nutrition. PubMed.
• Cheok A et al. (2022). Betalain-rich dragon fruit (pitaya) consumption improves vascular function in men and women. American Journal of Clinical Nutrition. ScienceDirect.
• Pansai N et al. (2023). Effects of dragon fruit oligosaccharides on immunity, gut microbiome, and their metabolites in healthy adults – A randomized double-blind placebo controlled study. Food Research International. ScienceDirect.
• Pansai N et al. (2020). Gut microbiota modulation and immune boosting properties of prebiotic dragon fruit oligosaccharides. International Journal of Food Science & Technology. Wiley.
• PMC (2025). Effects of Frozen Red Dragon Fruit Consumption on Metabolic Markers in Healthy Subjects and Individuals at Risk of Type 2 Diabetes.
• ScienceDirect (2025). Dragon fruit: Exploring bioactive compounds and their promising role in functional food innovation and value-added products.
• ResearchGate (2020). The effects of betalain-rich cacti (dragon fruit and cactus pear) on endothelial and vascular function: a systematic review of animal and human studies.
• Biology Insights. Where Is Pitaya From? The Origin of Dragon Fruit.
• Mexico News Daily. Taste of Mexico: Pitahaya fruit.